Emerging drugs for the treatment of mucopolysaccharidoses-Reference-Cited by-同舟云学术

Emerging drugs for the treatment of mucopolysaccharidoses

Published:2016-01-02 Issue:1 Volume:21 Page:9-26
ISSN:1472-8214
Container-title:Expert Opinion on Emerging Drugs
language:en
Short-container-title:Expert Opinion on Emerging Drugs

Author:

Giugliani Roberto,Federhen Andressa,Vairo Filippo,Vanzella Cláudia,Pasqualim Gabriela,da Silva Letícia Machado Rosa,Giugliani Luciana,de Boer Ana Paula Kurz,de Souza Carolina Fishinger Moura,Matte Ursula,Baldo Guilherme

Publisher

Informa Healthcare

Subject

Pharmacology (medical),Pharmacology

Link

http://www.tandfonline.com/doi/pdf/10.1517/14728214.2016.1123690

Reference122 articles.

1. Chondro-osteo-dystrophy

2. A Newly Recognized Forme Fruste of Hurler's Disease (Gargoylism)* *From the Departments of Ophthalmology, Dermatology, and Pediatrics, Hospital of the University of Pennsylvania, Children's Hospital of Philadelphia, and University of Pennsylvania Medical School.

3. Mental retardation associated with acid mucopolysacchariduria (heparitin sulfate type)

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dental Profile of Brazilian Patients with Rare Skeletal Genetic Disorders: Clinical Features and Associated Factors;Healthcare;2024-05-19

2. Multisystem Involvement in a Pediatric Patient With Suspected Mucopolysaccharidosis: A Case Report;Cureus;2024-05-19

3. Reduction of lysosome abundance and GAG accumulation after odiparcil treatment in MPS I and MPS VI models;Molecular Genetics and Metabolism Reports;2023-12

4. Management of MPS-I using ERT: The Egyptian experience;2023-11-16

5. Carbohydrate‐Based Therapeutics for Lysosomal Storage Disorders;Carbohydrate‐Based Therapeutics;2023-09-05